Bayesian Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
-10,900
| Closed | -$19.9K | – | 702 |
|
|
2024
Q1 | $19.9K | Buy |
+10,900
| New | +$19.9K | ﹤0.01% | 746 |
|
|
2022
Q4 | – | Sell |
-68,600
| Closed | -$22K | – | 755 |
|
|
2022
Q3 | $22K | Sell |
68,600
-235,500
| -77% | -$75.5K | ﹤0.01% | 641 |
|
|
2022
Q2 | $107K | Buy |
+304,100
| New | +$107K | 0.02% | 682 |
|
|
2020
Q4 | – | Sell |
-35,279
| Closed | -$89K | – | 444 |
|
|
2020
Q3 | $89K | Buy |
+35,279
| New | +$89K | 0.02% | 485 |
|